We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.38B
AUM Growth
+$173M
Cap. Flow
+$42.8M
Cap. Flow %
0.98%
Top 10 Hldgs %
17.34%
Holding
313
New
35
Increased
107
Reduced
82
Closed
58

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$26.6M
2
PFE icon
Pfizer
PFE
+$23.1M
3
MSFT icon
Microsoft
MSFT
+$23M
4
EBAY icon
eBay
EBAY
+$22.7M
5
BKD icon
Brookdale Senior Living
BKD
+$19.7M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$132M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$23M
3
ABBV icon
AbbVie
ABBV
+$21.5M
4
AAPL icon
Apple
AAPL
+$19.6M
5
BBBY
Bed Bath & Beyond Inc
BBBY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Healthcare 22.73%
3 Financials 22.23%
4 Consumer Discretionary 7.43%
5 Communication Services 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWTR
226
DELISTED
Twitter, Inc.
TWTR
$1.19M 0.03%
25,567
– –
HCSG icon
227
Healthcare Services Group
HCSG
$1.63B
$1.11M 0.03%
38,372
– –
VIVO
228
DELISTED
Meridian Bioscience Inc
VIVO
$932K 0.02%
42,800
+2,800
+7% +$64.2K
SWH
229
DELISTED
Stanley Black & Decker, Inc.
SWH
– –
-3,000
Closed -$314K
BIIB icon
230
Biogen
BIIB
$30.4B
$609K 0.01%
1,992
+639
+47% +$203K
ITUB icon
231
Itaú Unibanco
ITUB
$91.6B
$609K 0.01%
112,498
+35,670
+46% +$170K
CELG
232
DELISTED
Celgene Corp
CELG
$566K 0.01%
8,112
+3,122
+63% +$247K
AMGN icon
233
Amgen
AMGN
$212B
$482K 0.01%
3,908
+1,127
+41% +$137K
REGN icon
234
Regeneron Pharmaceuticals
REGN
$72.9B
$478K 0.01%
1,591
-74,493
-98% -$23M
BZT
235
DELISTED
BEAZER HOMES USA, INC. TANGIBLE EQUITY UNIT
BZT
– –
0
– –
MET icon
236
MetLife
MET
$62.7B
$395K 0.01%
8,393
– –
CNH
237
CNH Industrial
CNH
$14.2B
$345K 0.01%
+34,492
New +$331K
PB icon
238
Prosperity Bancshares
PB
$8.82B
$309K 0.01%
4,671
– –
TCBI icon
239
Texas Capital Bancshares
TCBI
$4.29B
$286K 0.01%
4,405
-1,015
-19% -$62.7K
SPNS
240
DELISTED
Sapiens International
SPNS
$223K 0.01%
+27,583
New +$209K
QIWI
241
DELISTED
QIWI PLC
QIWI
$214K ﹤0.01%
+6,170
New +$250K
INFI
242
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$211K ﹤0.01%
+17,724
New +$238K
MDVN
243
DELISTED
MEDIVATION, INC.
MDVN
$211K ﹤0.01%
+6,568
New +$242K
TLRA
244
DELISTED
Telaria, Inc.
TLRA
$201K ﹤0.01%
48,757
+16,828
+53% +$77.2K
OREX
245
DELISTED
Orexigen Therapeutics, Inc.
OREX
$150K ﹤0.01%
2,310
+1,279
+124% +$86.5K
ADI icon
246
Analog Devices
ADI
$178B
– –
-201,650
Closed -$10.3M
BDX icon
247
Becton Dickinson
BDX
$45.8B
– –
-174,250
Closed -$18.8M
DXCM icon
248
DexCom
DXCM
$28.9B
– –
-1,940,000
Closed -$17.2M
FLS icon
249
Flowserve
FLS
$9.38B
– –
-212,047
Closed -$16.7M
GOOG icon
250
Alphabet (Google) Class C
GOOG
$4.07T
– –
-4,743,995
Closed -$132M
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Polar Capital held 313 positions worth $4.38B, up 4.1% from $4.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Polar Capital's Q1 2014 filing shows 35 new, 107 increased, 82 reduced and 58 closed positions. Its largest new stake was IQVIA: 528,000 shares worth $26.8M. The largest sale was Alphabet (Google) Class C, an estimated $132M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2014 buy was IQVIA: 528,000 shares worth $26.8M.
  • Polar Capital added most to Pfizer in Q1 2014, an estimated $23.1M increase.
  • Polar Capital's biggest Q1 2014 reduction was Regeneron Pharmaceuticals, cutting an estimated $23M.
  • Polar Capital fully exited Alphabet (Google) Class C in Q1 2014, selling an estimated $132M.
  • Polar Capital's ten largest holdings make up 17% of its $4.38B portfolio in Q1 2014.
  • Polar Capital opened 35 new positions and closed 58 in Q1 2014.
  • Polar Capital's portfolio value rose 4.1% quarter-over-quarter to $4.38B.

Based on Polar Capital's 13F filing for Q1 2014, filed 7 May 2014.